Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials-Reference-Cited by-同舟云学术

Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials

Published:2011-03 Issue:5 Volume:47 Page:656-666
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Lee Anne W.M.,Tung Stewart Y.,Ngan Roger K.C.,Chappell Rick,Chua Daniel T.T.,Lu T.X.,Siu Lillian,Tan Terence,Chan L.K.,Ng W.T.,Leung T.W.,Fu Y.T.,Au Gordon K.H.,Zhao C.,O’Sullivan Brian,Tan E.H.,Lau W.H.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference28 articles.

1. Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone;Yeh;Int J Radiat Oncol Biol Phys,2005

2. Nasopharyngeal carcinoma treated by radical radiotherapy alone: ten-year experience of a single institution;Yi;Int J Radiat Oncol Biol Phys,2006

3. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup Study 0099;Al-Sarraf;J Clin Oncol,1998

4. Radiotherapy alone in patients with advanced nasopharyngeal cancer: comparison with an Intergroup study – is combined modality treatment really necessary?;Chow;Radiother Oncol,2002

5. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group;Lee;J Clin Oncol,2005

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-Compared with High-Dose Regimen of Induction Chemotherapy in Locally Advanced Nasopharyngeal Cancer: A Systematic Review and Meta-analysis;South Asian Journal of Cancer;2024-08-23

2. Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial;The Lancet;2024-06

3. Clinicopathological study on diameter of extranodal extension of cervical metastatic lymph nodes in the prognosis of oral cancer;Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology;2024-06

4. TPF induction chemotherapy versus PF adjuvant chemotherapy plus concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: a multicenter, randomized controlled phase III trial;2024-04-26

5. Radiomics-based nomogram guides adaptive de-intensification in locoregionally advanced nasopharyngeal carcinoma following induction chemotherapy;European Radiology;2024-03-22